Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng-Fu Chen

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 23, 2013
Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivitySheng-Fu Chen, Hann-Chorng Kuo
International Urology and Nephrology|August 14, 2025
Clinical efficacy and urodynamic predictors of successful treatment outcomes following urethral sphincter botulinum toxin A injection in women with non-spinal cord neurogenic voiding dysfunctionSheng-Fu Chen, Hann-Chorng Kuo
Tzu Chi Medical Journal|April 29, 2021
Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?Sheng-Fu Chen, Hann-Chorng Kuo
Toxins|February 24, 2023
Urethral Sphincter Botulinum Toxin A Injection for Non-Spinal Cord Injured Patients with Voiding Dysfunction without Anatomical Obstructions: Which Patients Benefit Most?Sheng-Fu Chen, Hann-Chorng Kuo
Lower Urinary Tract Symptoms|January 31, 2018
Therapeutic efficacy of low-dose (25 mg) mirabegron therapy for patients with mild to moderate overactive bladder symptoms due to central nervous system diseasesSheng-Fu Chen, Hann-Chorng Kuo
International Urology and Nephrology|November 30, 2023
Management of spinal cord injury patients with neurogenic lower urinary tract dysfunction using minimally invasive and surgical therapies in TaiwanSheng-Fu Chen, Hann-Chorng Kuo
Lower Urinary Tract Symptoms|March 2, 2022
Interventional management and surgery of neurogenic lower urinary tract dysfunction in patients with chronic spinal cord injury: A urologist's perspectiveSheng-Fu Chen, Hann-Chorng Kuo
Neurourology and Urodynamics|October 14, 2020
Will detrusor acontractility recover after medical or surgical treatment? A longitudinal long-term urodynamic follow-upSheng-Fu Chen, Chung-Hsin Peng, Hann-Chorng Kuo
Tzu Chi Medical Journal|April 10, 2020
Role of videourodynamic study in precision diagnosis and treatment for lower urinary tract dysfunctionYuan-Hong Jiang, Sheng-Fu Chen, Hann-Chorng Kuo
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Quantitative and qualitative analyses of DNA fragments based on electrical charge detection on a portable electrophoresis deviceGin-Shin Chen, Sheng-Fu Chen, Chih-Cheng Lu
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 23, 2013
Therapeutic outcome and patient adherence to repeated onabotulinumtoxinA detrusor injections in chronic spinal cord-injured patients and neurogenic detrusor overactivitySheng-Fu Chen, Hann-Chorng Kuo
International Urology and Nephrology|August 14, 2025
Clinical efficacy and urodynamic predictors of successful treatment outcomes following urethral sphincter botulinum toxin A injection in women with non-spinal cord neurogenic voiding dysfunctionSheng-Fu Chen, Hann-Chorng Kuo
Tzu Chi Medical Journal|April 29, 2021
Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?Sheng-Fu Chen, Hann-Chorng Kuo
Toxins|February 24, 2023
Urethral Sphincter Botulinum Toxin A Injection for Non-Spinal Cord Injured Patients with Voiding Dysfunction without Anatomical Obstructions: Which Patients Benefit Most?Sheng-Fu Chen, Hann-Chorng Kuo
Lower Urinary Tract Symptoms|January 31, 2018
Therapeutic efficacy of low-dose (25 mg) mirabegron therapy for patients with mild to moderate overactive bladder symptoms due to central nervous system diseasesSheng-Fu Chen, Hann-Chorng Kuo
International Urology and Nephrology|November 30, 2023
Management of spinal cord injury patients with neurogenic lower urinary tract dysfunction using minimally invasive and surgical therapies in TaiwanSheng-Fu Chen, Hann-Chorng Kuo
Lower Urinary Tract Symptoms|March 2, 2022
Interventional management and surgery of neurogenic lower urinary tract dysfunction in patients with chronic spinal cord injury: A urologist's perspectiveSheng-Fu Chen, Hann-Chorng Kuo
Neurourology and Urodynamics|October 14, 2020
Will detrusor acontractility recover after medical or surgical treatment? A longitudinal long-term urodynamic follow-upSheng-Fu Chen, Chung-Hsin Peng, Hann-Chorng Kuo
Tzu Chi Medical Journal|April 10, 2020
Role of videourodynamic study in precision diagnosis and treatment for lower urinary tract dysfunctionYuan-Hong Jiang, Sheng-Fu Chen, Hann-Chorng Kuo
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Quantitative and qualitative analyses of DNA fragments based on electrical charge detection on a portable electrophoresis deviceGin-Shin Chen, Sheng-Fu Chen, Chih-Cheng Lu
Pageof 7